Athyrium Provides $100MM Credit Facility to Recro
Recro Pharma secured a $100 million credit facility from funds managed by Athyrium Capital Management, a healthcare-focused investment firm.
November 21, 2017
Alkermes | Athyrium Capital Management | Recro Pharma | Richard Pines
ABF Journal